Home LiteratureArticle Details
PMID: 2412939 Published · ppublish English Journal Article

Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli.

Gene ·Vol. 35 ·No. 3 ·1985-00-00 ·Pages 249-58

Kotewicz ML, D'Alessio JM, Driftmier KM, Blodgett KP, Gerard GF

Abstract

A pBR322-derived expression vector, plasmid pKD1, was constructed containing the strong leftward promoter (pL) of bacteriophage lambda, the ribosome-binding site (RBS) of the cII gene of lambda, and a unique downstream NdeI restriction site for construction of an ATG initiation codon. The section of the pol gene of Moloney murine leukemia virus (M-MLV) that codes for reverse transcriptase (RT) was cloned into the NdeI site of this vector generating the plasmid pRT103. Upon thermal induction, enzymatically active RT was expressed in Escherichia coli [pRT103]. The identity of this activity was confirmed by its template specificity and its sensitivity to inhibition by immunoglobulin G (IgG) prepared against authentic murine RT. RT represented 20% of the newly synthesized protein in these cells 20 min after induction.

MeSH Terms
Bacteriophage lambda/genetics Cloning, Molecular DNA, Recombinant Escherichia coli/genetics Gene Expression Regulation Molecular Weight Moloney murine leukemia virus/genetics Protein Conformation RNA-Directed DNA Polymerase/genetics
Chemicals
DNA, Recombinant RNA-Directed DNA Polymerase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kotewicz M L
D'Alessio J M
Driftmier K M
Blodgett K P
Gerard G F
Article Info
Journal
Gene
Abbr.
Gene
ISSN
0378-1119
Published
1985-00-00
Pages
249-58
Language
English
Region
Netherlands
NLM ID
7706761
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]